Botwood Nicholas A.J.

Head of R&D, CMO

Officer

Latest Insider Transactions

9 transactions (past 365 days)

SNDX
CMO
Exercise Conversion
$431.7K
31,235 shares @ $13.82
Filed 2026-06-12Trade 2026-06-12
Syndax Pharmaceuticals Inc
SNDX
CMO
Sale
$566.6K
31,235 shares @ $18.14
Filed 2026-06-12Trade 2026-06-12
Syndax Pharmaceuticals Inc
SNDX
CMO
Exercise Conversion
$431.7K
31,235 shares @ $13.82
Filed 2026-06-12Trade 2026-06-12
Syndax Pharmaceuticals Inc
SNDX
CMO
Exercise Conversion
$311.2K
22,515 shares @ $13.82
Filed 2026-06-12Trade 2026-06-11
Syndax Pharmaceuticals Inc
SNDX
CMO
Sale
$617K
34,280 shares @ $18.00
Filed 2026-06-12Trade 2026-06-11
Syndax Pharmaceuticals Inc
SNDX
CMO
Exercise Conversion
$311.2K
22,515 shares @ $13.82
Filed 2026-06-12Trade 2026-06-11
Syndax Pharmaceuticals Inc
SNDX
CMO
Award
$0
24,000 shares @ $0.00
Filed 2026-02-06Trade 2026-02-04
Syndax Pharmaceuticals Inc
SNDX
CMO
Award
$0
36,000 shares @ $0.00
Filed 2026-02-06Trade 2026-02-04
Syndax Pharmaceuticals Inc
SNDX
CMO
Award
$3M
144,700 shares @ $20.43
Filed 2026-02-06Trade 2026-02-04
Syndax Pharmaceuticals Inc